Northern Cross’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $18.5M | Sell |
860,538
-21,640,266
| -96% | -$466M | 6.64% | 5 |
|
|
2018
Q2 | $547M | Sell |
22,500,804
-1,998,421
| -8% | -$48.6M | 9.66% | 5 |
|
|
2018
Q1 | $419M | Buy |
24,499,225
+2,304,437
| +10% | +$39.4M | 6.88% | 6 |
|
|
2017
Q4 | $421M | Sell |
22,194,788
-569,597
| -3% | -$10.8M | 5.46% | 6 |
|
|
2017
Q3 | $401M | Buy |
22,764,385
+4,968,806
| +28% | +$87.5M | 5.16% | 6 |
|
|
2017
Q2 | $591M | Buy |
17,795,579
+2,184,172
| +14% | +$72.6M | 7.62% | 6 |
|
|
2017
Q1 | $501M | Buy |
+15,611,407
| New | +$501M | 6.8% | 6 |
|